Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 109

Sort by

Sort Order Select

Journal Articles

Hypoimmune, Allogeneic CD22-Directed CAR T Cells That Evade Innate and Adaptive Immune Rejection for the Treatment of Large B Cell Lymphoma Patients That Are Relapsed/Refractory to CD19-Directed CAR T Cell Therapy

Blood (2023) 142 (Supplement 1): 3437.

https://doi.org/10.1182/blood-2023-187096

Published: 2023

Journal Articles

CD33 CAR T-Cells (CD33CART) for Children and Young Adults with Relapsed/Refractory AML: Dose-Escalation Results from a Phase I/II Multicenter Trial

Blood (2023) 142 (Supplement 1): 771.

https://doi.org/10.1182/blood-2023-179667

Published: 2023

Journal Articles

Phase 1 Study of SC291, a Hypoimmune, Allogeneic CD19-Directed CAR T Cell Therapy for Relapsed/Refractory B-Cell Malignancies (ARDENT) - Initial Clinical Data

Sattva S. Neelapu, L. Elizabeth Budde, Joseph P McGuirk, Saurabh Dahiya, Abhinav Deol, Philip A. Thompson, Nitin Jain, Matthew A Lunning, Xiaomeng Hu, Boris Gorovits, Danielle Quarles, Barbara Metallo, Meghan Flaherty, Weidong Zhang, Hosein Kouros-Mehr, Terry J. Fry, Sonja Schrepfer

Blood (2023) 142 (Supplement 1): 6852.

https://doi.org/10.1182/blood-2023-179441

Published: 2023

Journal Articles

T-Bet Overexpression Increases 4-1BB-Costimulated CAR T Cell Potency

Jennifer Cimons, Kole R. Degolier, Michael Yarnell, M. Eric Kohler, Terry J. Fry

Blood (2023) 142 (Supplement 1): 4816.

https://doi.org/10.1182/blood-2023-186902

Published: 2023

Journal Articles

Runx2 Overexpression Enhances Potency and Counteracts Exhaustion in CD8+ CAR T Cells

Kole R. Degolier, Etienne Danis, Jennifer Cimons, Michael Yarnell, Ross Kedl, M. Eric Kohler, James Scott-Browne, Terry J. Fry

Blood (2023) 142 (Supplement 1): 2082.

https://doi.org/10.1182/blood-2023-186898

Published: 2023

Journal Articles

Development of a Novel, Allogeneic GPRC5D-Directed CAR for Treatment of Multiple Myeloma Patients

Jeremy Kinder, Chanel Athena Estrada, Brian Granger, Allison O'Rourke, Ouwen Liang, Aaron Lampano, Garrett Zipp, Vandana Chaturvedi, Xiaomeng Hu, Chi Young, Neal van Hoeven, Sonja Schrepfer, Terry J. Fry

Blood (2023) 142 (Supplement 1): 3290.

https://doi.org/10.1182/blood-2023-189665

Published: 2023

Journal Articles

Immune-Effector-Cell-Associated-Neurotoxicity-Syndrome (ICANS) Pathophysiology Is Mediated By Microglia TGF-β-Activated Kinase-1 Signaling

Janaki Manoja Vinnakota, Francesca Biavasco, Marius Schwabenland, Chintan Chhatbar, Rachael C Adams, Daniel Erny, Sandra Duquesne, Nadia El Khawanky, Henrike Salié, Dimitrios Athanassopoulos, Lukas Braun, Dominik Schmidt, Viktor Fetsch, Rebeka N. Javorniczky, Jenny N.H.G Ho, Reinhard Marks, Ralph Wäsch, Federico Simonetta, Geoffroy Andrieux, Dietmar Pfeifer, Gianni Monaco, Christian Capitini, Terry J. Fry, Thomas Blank, Bruce R Blazar, Eva-Maria Wagner Drouet, Matthias Theobald, Clemens Sommer, Matthias Stelljes, Christian Reicherts, Astrid Jeibmann, Jens Schittenhelm, Camelia-Maria Monoranu, Andreas Rosenwald, K. Martin Kortüm, Leo Rasche, Hermann Einsele, Philipp Tobias Meyer, Joachim Brumberg, Andreas Mackensen, Michael von Bergwelt-Baildon, Roland Coras, Nathalie L. Albert, Laura M. Bartos, Matthias Brendel, Adrien Holzgreve, Melanie Boerries, Crystal L. Mackall, Justus Duyster, Natalie Koehler, Felix Strübing, Bertram Bengsch, Marco Ruella, Marion Subklewe, Louisa von Baumgarten, Saar Gill, Marco Prinz, Robert Zeiser

Blood (2023) 142 (Supplement 1): 100.

https://doi.org/10.1182/blood-2023-184867

Published: 2023

Journal Articles

In Vitro and In Vivo Specificity and Biodistribution of a Novel CD8-Targeted Fusosome

Hemantkumar Chavan, Shirisha Amatya, Valeria Berlfein, Patricia Cruite, Vandana Chaturvedi, Vasily Vagin, Neal van Hoeven, Jagesh Shah, Terry J. Fry, Boris Gorovits, Sundeep Chandra

Blood (2023) 142 (Supplement 1): 3630.

https://doi.org/10.1182/blood-2023-190158

Published: 2023

Journal Articles

Murine allogeneic CAR T cells integrated before or early after posttransplant cyclophosphamide exert antitumor effects

Michael T. Patterson, Shanzay M. Khan, Natalia S. Nunes, Rochelle E. Fletcher, Jing Bian, Ashley D. Hadjis, Michael A. Eckhaus, Suresh K. Mendu, Alessandra de Paula Pohl, David J. Venzon, Hyoyoung Choo-Wosoba, Kazusa Ishii, Haiying Qin, Terry J. Fry, Maggie Cam, Christopher G. Kanakry

Blood (2023) 141 (6): 659–672.

https://doi.org/10.1182/blood.2022016660

Published: 2023

Includes: Supplemental data

Journal Articles

Functional T Cell Assays Are Predictive of Pre-Clinical Potency to Generate Allogeneic, Hypoimmune CD19 CAR T Cells

Darin Salloum, PhD, Kavita Tundwal, Divy Kangeyan, PhD, Adam Johnson, Neal van Hoeven, PhD, Brian Granger, Jesus Moreno, Ouwen Liang, Pascal Beauchesne, Terry J. Fry, Aaron Foster

Blood (2022) 140 (Supplement 1): 4524–4525.

https://doi.org/10.1182/blood-2022-168372

Published: 2022

Journal Articles

CD8-Targeted, Integrating Viral Vectors Transduce Resting T Cells and Enable Extracorporeal Delivery (ECD) for Rapid CAR T Cell Therapies

Jesse Green, Adam Johnson, Brian Granger, Ouwen Liang, Jesus Moreno, Andrew Tucker, Hallee Wright, Brian Dolinski, Hanane Ennajdaoui, Semih Tareen, Neal van Hoeven, PhD, Jagesh Shah, Kutlu Elpek, Aaron Foster, Terry J. Fry

Blood (2022) 140 (Supplement 1): 7768–7769.

https://doi.org/10.1182/blood-2022-162705

Published: 2022

Journal Articles

A Dual-Antigen Targeting, Hypoimmune Allogeneic CAR T to Evade Innate and Adaptive Immune Rejection and Overcome Antigen Escape

Adam Johnson, Hallee Wright, Xiaomeng Hu, Neal van Hoeven, PhD, Brian Granger, Ouwen Liang, Jesus Moreno, Meghan Lamba, Chi Young, Andrew McAlister, Terry J. Fry, Sonja Schrepfer, Aaron Foster

Blood (2022) 140 (Supplement 1): 4552–4553.

https://doi.org/10.1182/blood-2022-168251

Published: 2022

Journal Articles

Utilization of the Tapestri Platform for Quantification of Single Cell Vector Copy Number in CAR T Cell Products

Lindsey A. Murphy, Alex Li, Saurabh Parikh, Shu Wang, Daniel Mendoza, Khushali Patel, Yilong Yang, Yue Wang, Terry J. Fry, Amanda C. Winters

Blood (2022) 140 (Supplement 1): 4992.

https://doi.org/10.1182/blood-2022-170671

Published: 2022

Journal Articles

CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CAR

Blood (2022) 140 (5): 451–463.

https://doi.org/10.1182/blood.2022015795

Published: 2022

Includes: Supplemental data

Journal Articles

The CD19 neg needle in the haystack

Nirali N. Shah, Terry J. Fry

Blood (2022) 140 (1): 4–6.

https://doi.org/10.1182/blood.2022016335

Published: 2022

Journal Articles

Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells

Blood (2021) 138 (24): 2469–2484.

https://doi.org/10.1182/blood.2021011898

Published: 2021

Includes: Supplemental data

Journal Articles

Multi-Modal Targeting of FLT3 with Chimeric Antigen Receptor T Cell Immunotherapy and Tyrosine Kinase Inhibition in High-Risk Pediatric Leukemias

Lisa M Niswander, Zachary Graff, Asen Bagashev, Lillie Leach, Terry J. Fry, Sarah K Tasian

Blood (2021) 138 (Supplement 1): 404.

https://doi.org/10.1182/blood-2021-147321

Published: 2021

Journal Articles

In Vivo Delivery of a CD20 CAR Using a CD8-Targeted Fusosome in Southern Pig-Tail Macaques ( M. nemestrina ) Results in B Cell Depletion

Blood (2021) 138 (Supplement 1): 2769.

https://doi.org/10.1182/blood-2021-148709

Published: 2021

Journal Articles

Overexpression of Rorγt in CAR T Cells Improves Persistence and Reduces Exhaustion

Jennifer Cimons, Mark Eric Kohler, Michael Yarnell, Terry J. Fry

Blood (2021) 138 (Supplement 1): 2801.

https://doi.org/10.1182/blood-2021-147011

Published: 2021

Journal Articles

Specificity of CD8-Targeted Fusosomes in Human PBMCs Using Single Cell RNA and T Cell Receptor Sequencing

Hina Iftikhar, Nikolas Balanis, Chamith Fonseka, Christopher Bandoro, Patricia Cruite, Samantha Davis, Shirisha Amatya, Zach Frye, Lauren Pepper, Michael Laska, Terry J. Fry, Jagesh V Shah, Saurabh Paliwal, Christina Chaivorapol

Blood (2021) 138 (Supplement 1): 3983.

https://doi.org/10.1182/blood-2021-149990

Published: 2021

NARROW

Hypoimmune, Allogeneic CD22-Directed CAR T Cells That Evade Innate and Adaptive Immune Rejection for the Treatment of Large B Cell Lymphoma Patients That Are Relapsed/Refractory to CD19-Directed CAR T Cell Therapy

CD33 CAR T-Cells (CD33CART) for Children and Young Adults with Relapsed/Refractory AML: Dose-Escalation Results from a Phase I/II Multicenter Trial

Phase 1 Study of SC291, a Hypoimmune, Allogeneic CD19-Directed CAR T Cell Therapy for Relapsed/Refractory B-Cell Malignancies (ARDENT) - Initial Clinical Data

T-Bet Overexpression Increases 4-1BB-Costimulated CAR T Cell Potency

Runx2 Overexpression Enhances Potency and Counteracts Exhaustion in CD8+ CAR T Cells

Development of a Novel, Allogeneic GPRC5D-Directed CAR for Treatment of Multiple Myeloma Patients

Immune-Effector-Cell-Associated-Neurotoxicity-Syndrome (ICANS) Pathophysiology Is Mediated By Microglia TGF-β-Activated Kinase-1 Signaling

In Vitro and In Vivo Specificity and Biodistribution of a Novel CD8-Targeted Fusosome

Murine allogeneic CAR T cells integrated before or early after posttransplant cyclophosphamide exert antitumor effects

Functional T Cell Assays Are Predictive of Pre-Clinical Potency to Generate Allogeneic, Hypoimmune CD19 CAR T Cells

CD8-Targeted, Integrating Viral Vectors Transduce Resting T Cells and Enable Extracorporeal Delivery (ECD) for Rapid CAR T Cell Therapies

A Dual-Antigen Targeting, Hypoimmune Allogeneic CAR T to Evade Innate and Adaptive Immune Rejection and Overcome Antigen Escape

Utilization of the Tapestri Platform for Quantification of Single Cell Vector Copy Number in CAR T Cell Products

CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CAR

The CD19 neg needle in the haystack

Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells

Multi-Modal Targeting of FLT3 with Chimeric Antigen Receptor T Cell Immunotherapy and Tyrosine Kinase Inhibition in High-Risk Pediatric Leukemias

In Vivo Delivery of a CD20 CAR Using a CD8-Targeted Fusosome in Southern Pig-Tail Macaques ( M. nemestrina ) Results in B Cell Depletion

Overexpression of Rorγt in CAR T Cells Improves Persistence and Reduces Exhaustion

Specificity of CD8-Targeted Fusosomes in Human PBMCs Using Single Cell RNA and T Cell Receptor Sequencing

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only